Inventor

LAPIDOT TSVEE

IL10 patents

⚠️ This page may combine multiple inventors who share the name “LAPIDOT TSVEE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

YEDA RES & DEV

6 patents

US7101708B1Sep 5, 2006

Hematopoietic cell composition for use in transplantation

YEDA RES & DEV27 citations92

US8029780B2Oct 4, 2011

Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same

YEDA RES & DEV18 citations89

US7198781B1Apr 3, 2007

Chimeric interleukin-6 soluble receptor/ligand proteins

YEDA RES & DEV12 citations82

US8367057B2Feb 5, 2013

Stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them

YEDA RES & DEV17 citations76

US7374912B2May 20, 2008

Nucleic acids encoding chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof

YEDA RES & DEV1 citations50

US9567371B2Feb 14, 2017

Short beta-defensin-derived peptides

YEDA RES & DEV1 citations49

LAPIDOT TSVEE

2 patents

US8241903B2Aug 14, 2012

Catecholamine receptor modulation

LAPIDOT TSVEE15 citations74

US9155780B2Oct 13, 2015

Short beta-defensin-derived peptides

LAPIDOT TSVEE1 citations47

HSC RES DEV LP

1 patent

US6353150B1Mar 5, 2002

Chimeric mammals with human hematopoietic cells

HSC RES DEV LP78 citations93

KOLLET ORIT

1 patent

US8252588B2Aug 28, 2012

Stem cells having increased sensitivity to SDF-1 and methods of generating and using same

KOLLET ORIT0 citations42